Maternal antioxidant treatment protects adult offspring against memory loss and hippocampal atrophy in a rodent model of developmental hypoxia

FASEB J. 2021 May;35(5):e21477. doi: 10.1096/fj.202002557RR.

Abstract

Chronic fetal hypoxia is one of the most common outcomes in complicated pregnancy in humans. Despite this, its effects on the long-term health of the brain in offspring are largely unknown. Here, we investigated in rats whether hypoxic pregnancy affects brain structure and function in the adult offspring and explored underlying mechanisms with maternal antioxidant intervention. Pregnant rats were randomly chosen for normoxic or hypoxic (13% oxygen) pregnancy with or without maternal supplementation with vitamin C in their drinking water. In one cohort, the placenta and fetal tissues were collected at the end of gestation. In another, dams were allowed to deliver naturally, and offspring were reared under normoxic conditions until 4 months of age (young adult). Between 3.5 and 4 months, the behavior, cognition and brains of the adult offspring were studied. We demonstrated that prenatal hypoxia reduced neuronal number, as well as vascular and synaptic density, in the hippocampus, significantly impairing memory function in the adult offspring. These adverse effects of prenatal hypoxia were independent of the hypoxic pregnancy inducing fetal growth restriction or elevations in maternal or fetal plasma glucocorticoid levels. Maternal vitamin C supplementation during hypoxic pregnancy protected against oxidative stress in the placenta and prevented the adverse effects of prenatal hypoxia on hippocampal atrophy and memory loss in the adult offspring. Therefore, these data provide a link between prenatal hypoxia, placental oxidative stress, and offspring brain health in later life, providing insight into mechanism and identifying a therapeutic strategy.

Keywords: brain; fetal hypoxia; hippocampus; memory; programming.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Antioxidants / therapeutic use
  • Ascorbic Acid / therapeutic use*
  • Atrophy / drug therapy*
  • Atrophy / etiology
  • Atrophy / metabolism
  • Atrophy / pathology
  • Dietary Supplements
  • Disease Models, Animal
  • Female
  • Fetal Growth Retardation / drug therapy
  • Fetal Growth Retardation / etiology
  • Fetal Growth Retardation / metabolism
  • Fetal Growth Retardation / pathology
  • Fetal Hypoxia / complications*
  • Hippocampus / drug effects*
  • Male
  • Memory Disorders / drug therapy*
  • Memory Disorders / etiology
  • Memory Disorders / metabolism
  • Memory Disorders / pathology
  • Pregnancy
  • Pregnancy Complications / drug therapy
  • Pregnancy Complications / etiology
  • Pregnancy Complications / metabolism
  • Pregnancy Complications / pathology
  • Prenatal Exposure Delayed Effects / drug therapy*
  • Prenatal Exposure Delayed Effects / etiology
  • Prenatal Exposure Delayed Effects / metabolism
  • Prenatal Exposure Delayed Effects / pathology
  • Rats
  • Rats, Wistar

Substances

  • Antioxidants
  • Ascorbic Acid